ArticleACS pharmacology & translational science2021

Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease.

Vicki Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.